Revvity
Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments.
Latest Revvity Content
App Note / Case Study
Discover Automated Tissue Homogenization for LC-MS Analysis
This application note explores how automated workstations for tissue sample weighing and homogenization can increase efficiency and quality of results.
Webinar
Real-World Insights on Cell and Gene Therapy Development: Navigating the Complexities of Critical Quality Attributes
In this webinar, you’ll gain insights from experts in CGT development who will explore their experiences of CQA assays, sharing advice on how to overcome the challenges you may face in your CGT journey.
Industry Insight
Next Generation Precision Genome Editing: Combining Multiple Advances To Create Safer Gene Therapies
In this article, Michelle Fraser and Amanda Haupthow discuss how engineered nucleases in combination with next-generation base editing platforms are paving the way for the development of novel treatments for genetic disorders and diseases.
Infographic
Gain Deeper Insights From Your 3D Cell Model Imaging
This infographic explores innovative tools and strategies for enhancing 3D cell model imaging that can help you achieve high-quality images and efficiently manage data.
How To Guide
Top Tips for Enhancing Single-Cell Sequencing
This guide explores the nuances of these challenges and presents promising strategies designed to overcome them, enabling researchers to access the full spectrum of cellular diversity and function in health and disease.
Video
Drug Discovery and CROs: A Journey Beyond Spreadsheets and Email
In this episode, we speak with Chris Stumpf, Director, Drug Discovery Informatics Solutions at Revvity Signals.
App Note / Case Study
A Novel Approach for Non-Invasive Liver Research
This case study utilizes non-invasive ultrasound imaging to visualize and quantify liver echogenicity and stiffness, providing critical insights into both disease progression and the efficacy of therapeutic interventions in mouse models.
Product News
Early Check Newborn Screening Study Taps Revvity To Provide Genome Sequencing
The North Carolina-based study will continue to test enrolled newborns for hundreds of childhood-onset rare genetic conditions.
Product News
Revvity Unveils a New Era of Automated Tuberculosis Testing
New and improved workflow now available that pairs Revvity’s T-SPOT™.TB test with the Auto-Pure 2400 liquid handling platform. Substantially lowers hands-on time, allowing for increased lab productivity.
Product News
Revvity Unveils a New Era of Automated Tuberculosis Testing
New and improved workflow now available that pairs Revvity’s T-SPOT™.TB test with the Auto-Pure 2400 liquid handling platform. Substantially lowers hands-on time, allowing for increased lab productivity.
Advertisement
